| Kyle Robert Ulrich, DO | |
|
1500 E Sherman Blvd, Muskegon, MI 49444-1854 | |
| (231) 672-3883 | |
| (231) 672-3973 |
| Full Name | Kyle Robert Ulrich |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 6 Years |
| Location | 1500 E Sherman Blvd, Muskegon, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881189520 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 5101027282 (Michigan) | Primary |
| 207R00000X | Internal Medicine | 5101023798 (Michigan) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Health Hackley Campus | Muskegon, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Specialty Services | 2365439544 | 79 |
News Archive
For people with long-standing rheumatoid arthritis, combined treatment with the new "biologic" drug adalimumab and methotrexate is about five times more effective than methotrexate alone, according to a new systematic review of studies.
The Huffington Post Investigative Fund: "In the past two years, the agency has received reports of six patient deaths and several dozen injuries linked to malfunctions in the systems, Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health, said in testimony prepared for a government hearing on Thursday. ... The FDA has been studying the issue for several years. Its latest concerns are surfacing as the government ramps up an ambitious plan to spend as much as $27 billion in stimulus money helping doctors and hospitals across the country purchase electronic medical records systems that rely on digital software rather than paper medical charts."
In a press release the U.S. Food and Drug Administration (FDA) released a plan for eliminating the backlog regarding orphan drug application status and also released plans for deadlines to clear the queues.
Nucleix Ltd., a leading cancer detection and screening company, announced today that the multi-center European study results with its Bladder EpiCheck urine test for the detection of bladder cancer recurrence, were published in the European Urology Oncology journal.
Despite improvements in death rates from cardiovascular disease (CVD) around the world, CVD remains a leading cause of death and ill health in the UK, where death rates are amongst the highest in the world. Reducing death rates from this disease remains high on the Government's agenda, yet attention to the classical risk factors may not provide all the answers.
› Verified 7 days ago
| Entity Name | Mercy Specialty Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629010384 PECOS PAC ID: 2365439544 Enrollment ID: O20040429000064 |
News Archive
For people with long-standing rheumatoid arthritis, combined treatment with the new "biologic" drug adalimumab and methotrexate is about five times more effective than methotrexate alone, according to a new systematic review of studies.
The Huffington Post Investigative Fund: "In the past two years, the agency has received reports of six patient deaths and several dozen injuries linked to malfunctions in the systems, Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health, said in testimony prepared for a government hearing on Thursday. ... The FDA has been studying the issue for several years. Its latest concerns are surfacing as the government ramps up an ambitious plan to spend as much as $27 billion in stimulus money helping doctors and hospitals across the country purchase electronic medical records systems that rely on digital software rather than paper medical charts."
In a press release the U.S. Food and Drug Administration (FDA) released a plan for eliminating the backlog regarding orphan drug application status and also released plans for deadlines to clear the queues.
Nucleix Ltd., a leading cancer detection and screening company, announced today that the multi-center European study results with its Bladder EpiCheck urine test for the detection of bladder cancer recurrence, were published in the European Urology Oncology journal.
Despite improvements in death rates from cardiovascular disease (CVD) around the world, CVD remains a leading cause of death and ill health in the UK, where death rates are amongst the highest in the world. Reducing death rates from this disease remains high on the Government's agenda, yet attention to the classical risk factors may not provide all the answers.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kyle Robert Ulrich, DO Po Box 776982, Chicago, IL 60677-6982 Ph: (231) 672-2119 | Kyle Robert Ulrich, DO 1500 E Sherman Blvd, Muskegon, MI 49444-1854 Ph: (231) 672-3883 |
News Archive
For people with long-standing rheumatoid arthritis, combined treatment with the new "biologic" drug adalimumab and methotrexate is about five times more effective than methotrexate alone, according to a new systematic review of studies.
The Huffington Post Investigative Fund: "In the past two years, the agency has received reports of six patient deaths and several dozen injuries linked to malfunctions in the systems, Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health, said in testimony prepared for a government hearing on Thursday. ... The FDA has been studying the issue for several years. Its latest concerns are surfacing as the government ramps up an ambitious plan to spend as much as $27 billion in stimulus money helping doctors and hospitals across the country purchase electronic medical records systems that rely on digital software rather than paper medical charts."
In a press release the U.S. Food and Drug Administration (FDA) released a plan for eliminating the backlog regarding orphan drug application status and also released plans for deadlines to clear the queues.
Nucleix Ltd., a leading cancer detection and screening company, announced today that the multi-center European study results with its Bladder EpiCheck urine test for the detection of bladder cancer recurrence, were published in the European Urology Oncology journal.
Despite improvements in death rates from cardiovascular disease (CVD) around the world, CVD remains a leading cause of death and ill health in the UK, where death rates are amongst the highest in the world. Reducing death rates from this disease remains high on the Government's agenda, yet attention to the classical risk factors may not provide all the answers.
› Verified 7 days ago
Kyle Nathaniel Turcic, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 1500 E Sherman Blvd, Muskegon, MI 49444 Phone: 231-672-2000 | |
Bartholomew David Sak, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1500 E Sherman Blvd, Muskegon, MI 49444 Phone: 231-672-3883 Fax: 231-672-3973 | |
Dr. Peyton Paul Faganel, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1675 Leahy St Ste 201a, Muskegon, MI 49442 Phone: 231-672-7800 | |
Jon Michael Carnahan, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1500 E Sherman Blvd, Muskegon, MI 49444 Phone: 231-672-3883 Fax: 231-672-3973 | |
Dr. Sripriya Ganesan, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1675 Leahy St Ste 304b, Muskegon, MI 49442 Phone: 231-728-1695 | |
Matthew Anthony Wagner, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 1500 E Sherman Blvd, Muskegon, MI 49444 Phone: 231-672-2000 | |
Dr. William Patrick Hughes, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1500 E Sherman Blvd, Muskegon, MI 49444 Phone: 231-672-3883 Fax: 231-672-3973 |